Login / Signup

Clinical added value of MRI to CT in patients scheduled for local therapy of colorectal liver metastases (CAMINO): study protocol for an international multicentre prospective diagnostic accuracy study.

Burak GörgecI HansenG KemmerichT SyversveenM Abu HilalE J T BeltR H C BisschopsT L BollenK BosschaM C BurgmansV CappendijkM T De BoerM D'HondtB EdwinH GielkensD J GrünhagenP GillardinP D GobardhanH H HartgrinkK HorsthuisN F M KokP A M KintJ W H KruimerW K G LeclercqD J LipsB LutinM MaasH A MarsmanM MoroneJ P PenningsJ PeringaW W Te RieleM VermaasD WichertsF E J A WillemssenB M ZonderhuisP M M BossuytR J SwijnenburgÅ A FretlandC VerhoefM G BesselinkJ Stokernull null
Published in: BMC cancer (2021)
The CAMINO study was registered in the Netherlands National Trial Register under number NL8039 on September 20th 2019.
Keyphrases
  • liver metastases
  • clinical trial
  • contrast enhanced
  • ejection fraction
  • computed tomography
  • prognostic factors
  • magnetic resonance
  • cross sectional
  • patient reported outcomes
  • double blind